Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Vacci-Test Signs New World-Wide Food Safety Licence with MagnaBioSciences

Abstract:
Vacci-Test Corporation ("Vacci-Test") is pleased to announce that it has completed a new exclusive licence agreement with MagnaBioSciences LLC ("MBS") of San Diego, California that gives Vacci-Test the world wide rights to the patented MBS magnetic technology for the detection of pathogens in the human food chain. The new agreement expands the terms of the existing agreement, signed in 2007, and includes MBS taking a minority ownership position in Vacci-test. Vacci-Test's first product to be developed under this new licence will be FoodChekTM-E.coli, a revolutionary new same shift test that is rapid, highly accurate and cost effective.

Vacci-Test Signs New World-Wide Food Safety Licence with MagnaBioSciences

CALGARY, AB, Canada | Posted on November 5th, 2008

Vacci-Test will be bringing a number of ground-breaking food safety tests to market beginning with FoodChekTM-E.coli in Q4 2008, to be quickly followed by other equally innovative tests for the detection of Salmonella and Listeria. FoodChekTM-E.coli is a breakthrough solution for meat-processors enabling them to easily and inexpensively deliver high quality and safe products to consumers. FoodChekTM-E.coli has already successfully completed field trials in two meat-processing plants and the development of FoodChekTM-Salmonella is currently underway.

Mr. Sandy MacPherson, Chairman of the Executive Operating Committee of Vacci-Test said "This new MBS agreement demonstrates our mutual commitment to food safety testing and the urgent need for more rapid, accurate and cost effective food safety tests in the food industry. For Vacci-Test this new licence provides broader, worldwide access for all of our new products in the global food safety market. I am also extremely pleased that MBS has expressed its confidence in Vacci-Test and its products by taking an ownership position in our company."

Dr. Ron Sager, CEO of MBS stated, "I am confident that by joining forces and taking an equity position in Vacci-Test that our shareholders will share in the success we know Vacci-Test will have in the burgeoning and valuable food safety market."

MagnaBioSciences, a subsidiary of Quantum Design and a world leading innovator in magnetic measurement devices is a privately held U.S. company based in San Diego, California specializing in the use of proprietary magnetic nanotechnology for diagnostic applications for the healthcare, veterinary and other industries.

####

About Vacci-Test Corporation
Vacci-Test is a privately held Canadian corporation based in Calgary, Alberta that specializes in the development and commercialization of proprietary food safety tests, based on magnetic nanotechnology, for the rapid and specific detection and quantitative measurement of pathogens in food.

This information release may contain certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its private filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please click here

Contacts:
Vacci-Test Corporation
William J. Hogan
Vice Chairman
(403) 269-9424
Email:
or
Vacci-Test Corporation
Suite 1005, 550 - 11th Avenue S.W.
Calgary, Alberta, Canada T2R 1M7
or
MagnaBioSciences LLC
Dr. Ron Sager
CEO
(858) 481-4400
or
MagnaBioSciences LLC
6325 Lusk Boulevard
San Diego, CA 92121, USA

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

MEMS & Sensors Technology Showcase: Finalists Announced for MEMS Executive Congress US 2014 October 23rd, 2014

Nanoparticle technology triples the production of biogas October 23rd, 2014

Announcements

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

Patents/IP/Tech Transfer/Licensing

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014

harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014

Food/Agriculture/Supplements

Smallest world record has 'endless possibilities' for bio-nanotechnology October 8th, 2014

Simple Detection of Toxic Compounds in Dairy Products October 6th, 2014

Iranian Scientists Separate Zinc Ion at Low Concentrations September 20th, 2014

Nanoscience makes your wine better September 17th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE